As recently described, RA patients carrying DR2 serology (HLADRB1*15 and 16 alleles) and DQB1*06 have an increased risk of ILD, whereas HLA-DRB1 Shared Epitope (SE) appears to be protective against ILD development [66]. Here, HLA-DRB1 is linked to interstitial lung disease.